Cambridge Investment Research Advisors, Inc. Organon & Co. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 51,669 shares of OGN stock, worth $761,084. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,669
Previous 49,964
3.41%
Holding current value
$761,084
Previous $1.03 Million
4.45%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding OGN
# of Institutions
793Shares Held
192MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$480 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$445 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$144 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$132 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.49MShares$110 Million0.31% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.75B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...